Optovue Solix Expert

OCT Optovue Solix and topography: understanding corneal asymmetry induced by dry eye syndrome

 

In this video, you will have the opportunity to discover how the Optovue Solix OCT and corneal topography help to understand corneal asymmetries caused by dry eye syndrome.


  • Optimizing indications in corneal refractive surgery or with premium implants is a critical challenge as well as ensuring a high level of precision in postoperative outcomes.

  • Dry eye induces remodeling of the corneal epithelium, which affects keratometry and topographic appearance, potentially leading to asymmetries in corneal topography.

  • The multimodality of the Solix OCT, including epimapping, combined with corneal topography, enables the monitoring of all variations induced by ocular surface disorders related to dry eye.

  • This multimodal corneal imaging is on the way to becoming a gold standard in refractive surgery, aiming to optimize refractive outcomes.

**Medical procedures, case studies, and practices mentioned in this content may vary based on regional standards, local regulations, and the discretion of providing healthcare professional. What may be considered appropriate and ethical in one country may differ in another.



Our experts

  • Adil El Maftouhi

    Mr Adil El Maftouhi

    • Adil El Maftouhi is an orthoptist specializing in ocular imaging and exploration at the Centre Ophtalmologique de Rive Geneva in Switzerland and the Institut Parisien d'Ophtalmologie in Paris, France. He is the author of international publications on OCT and OCT-A. He has also published several peer-reviewed articles, such as "OCT and Dry Eye Disease" and "OCT: The Intelligence of the Epithelium."

    • Adil El Maftouhi works on the development and utilization of various imaging systems available in ophthalmology to maximize the potential of each system for clinical benefit. At the same time, he contributes to the development of new imaging applications and software, particularly in OCT technology. Mr. El Maftouhi is also involved in clinical and pharmacological research projects in the fields of medical retina, glaucoma, and low vision.